Evidence map›Paper›PMID 41686384›Full record

ArticleInternational journal of clinical oncology2026

Online peer support for breast cancer survivors: protocol for a decentralized multicenter open-label pilot randomized controlled trial (HOPE-BC study).

Ken Kurisu, Yosuke Uchitomi, Naomi Sakurai, Maiko Fujimori, Nobuya Akizuki, Asao Ogawa, Akifumi Kurata, Tadahiro Izutani, Keita Mori, Tatsuo Akechi and 1 more

Abstract readClinical Trial Protocol
In one paragraph

Article in International journal of clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ken KurisuDepartment of Cancer Survivorship and Digital Medicine, The Jikei University School of Medicine, Tokyo, Japan. chrischris0801@gmail.com.ORCID http://orcid.org/0000-0002-1831-8987
Yosuke UchitomiDepartment of Cancer Survivorship and Digital Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Naomi SakuraiCancer Solutions Inc., Tokyo, Japan.
Maiko FujimoriDivision of Survivorship Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Nobuya AkizukiDepartment of Psycho-Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Asao OgawaDivision of Psycho-Oncology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, Japan.
Akifumi KurataDaiichi Sankyo Co., Ltd., Tokyo, Japan.
Tadahiro IzutaniDaiichi Sankyo Co., Ltd., Tokyo, Japan.
Keita MoriDepartment of Biostatistics, Shizuoka Cancer Center, Shizuoka, Japan.
Tatsuo AkechiDepartment of Psychiatry and Cognitive-Behavioral Medicine, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.
Toshinari YamashitaDepartment of Breast Surgery and Oncology, Kanagawa Cancer Center, Yokohama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe effectiveness of peer support for breast cancer survivors has varied substantially, and no previous study has examined patient-supporter matching. This study protocol describes a decentralized, multicenter, open-label pilot randomized controlled trial designed to explore the effectiveness of online peer support for breast cancer survivors and to develop a matching algorithm for use in future research.

methodsFifty breast cancer survivors within 3 years of completing initial treatment will be recruited and will provide electronic informed consent. They will be randomly assigned to either the peer support group, which will schedule a peer support session immediately after registration, or the waitlist control group, which will schedule their session 2 weeks later. Peer support sessions will be conducted online by two trained peer supporters. The primary outcome is the score on the UCLA Loneliness Scale, assessed 1 week after the session in the peer support group and at the end of the 2-week waiting period in the control group. Secondary outcomes include satisfaction with peer support and other psychosocial measures, all assessed through an electronic patient-reported outcome system. Effect sizes will be calculated to inform sample size estimation for future trials. Potential factors associated with satisfaction, such as similarity between participants and peer supporters, will also be explored to guide matching algorithm development. DISCUSSION: The findings will inform a future confirmatory trial incorporating an optimized matching algorithm. Trial registration UMIN000056741.

Indexed as

Breast NeoplasmsCancer SurvivorsPeer GroupSocial SupportAdultFemaleHumansMiddle AgedMulticenter Studies as TopicPilot ProjectsRandomized Controlled Trials as TopicBreast cancer survivorsDecentralized clinical trialMatching algorithmPeer supportRandomized controlled trial

Identifiers

PMID41686384
PMCPMC13018041

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.